Name: DOK5 | Sequence: fasta or formatted (306aa) | NCBI GI: 29544726 | |
Description: docking protein 5
|
Referenced in: Non-Receptor Tyrosine Kinase Pathways
| ||
Composition:
Amino acid Percentage Count Longest homopolymer A alanine 6.9 21 2 C cysteine 2.6 8 1 D aspartate 4.2 13 2 E glutamate 7.2 22 1 F phenylalanine 3.9 12 1 G glycine 4.6 14 1 H histidine 2.9 9 1 I isoleucine 4.6 14 1 K lysine 5.9 18 2 L leucine 9.2 28 2 M methionine 2.6 8 1 N asparagine 3.6 11 2 P proline 3.6 11 1 Q glutamine 4.9 15 1 R arginine 8.2 25 2 S serine 7.8 24 2 T threonine 5.6 17 2 V valine 5.6 17 1 W tryptophan 2.0 6 1 Y tyrosine 4.2 13 1 |
Comparative genomics:
Search single species RefSeq proteins at NCBI
Search summary
Figure data | ||
Related human proteins:Protein Relative score Description Self-match 1.000 docking protein 5 DOK6 0.715 docking protein 6 DOK4 0.575 docking protein 4 DOK1 0.078 docking protein 1 DOK2 0.070 docking protein 2 DOK3 0.053 docking protein 3 isoform 1 FRS3 0.048 fibroblast growth factor receptor substrate 3 FRS2 0.041 fibroblast growth factor receptor substrate 2 [Homo... FRS2 0.041 fibroblast growth factor receptor substrate 2 [Homo... IRS1 0.038 insulin receptor substrate 1 DOK7 0.027 downstream of tyrosine kinase 7 IRS4 0.012 insulin receptor substrate 4 CDCP1 0.012 CUB domain-containing protein 1 isoform 1 IRS2 0.008 insulin receptor substrate 2 TLN2 0.008 talin 2 GRB14 0.008 growth factor receptor-bound protein 14 ACCSL 0.007 1-aminocyclopropane-1-carboxylate synthase homolog ...Human BLASTP results (used to prepare the table) |
Gene descriptions are from NCBI RefSeq. Search results were obtained with NCBI BLAST and RefSeq entries. When identical proteins are present, the self-match may not be listed first in BLASTP output. In such cases, the table above has been reordered to place it first.
See About the Figures for the scoring system used in the figure above right. The same scoring system was used in the table of BLASTP results.
Guide to the Human Genome
Copyright © 2010 by Stewart Scherer. All rights reserved.